{"id":"W2789935709","doi":"10.1093/ecco-jcc/jjx180.673","title":"P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results","year":2018,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Takeda (Canada); St. Paul's Hospital","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Discontinuation; Internal medicine; Interim analysis; Demographics; Crohn's disease; Interim; Gastroenterology; Surgery; Disease; Clinical trial; Demography","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00144853,0.0003219362,0.0005427356,0.0008253881,0.001351994,0.001499867,0.0006876513,0.000348432,0.001184131],"category_scores_gemma":[0.002741449,0.0002767496,0.000906942,0.00274679,0.00052097,0.0004903761,0.001025422,0.0007118528,0.0002587523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01436216,"about_ca_system_score_gemma":0.02143879,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9025047,"about_ca_topic_score_gemma":0.9262637,"domain_scores_codex":[0.9985309,0.0001255756,0.0001090128,0.0001493652,0.0006043972,0.0004806712],"domain_scores_gemma":[0.9964254,0.0001352869,0.0009179487,0.0001448449,0.001685043,0.0006914478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001602325,0.0001140622,0.9876747,0.00006607614,0.0001863988,0.0001148648,0.0003101072,0.0002443206,0.0001687133,0.00008709316,0.001376849,0.008054474],"study_design_scores_gemma":[0.0001313146,0.0003288622,0.9965328,0.00004723142,0.0001454442,0.000125485,0.0004331897,0.0003644463,0.0001061692,0.00002403527,0.001745011,0.00001594481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872093,0.0007916189,0.0001093396,0.0002434576,0.00001005461,0.0001331078,0.00975546,0.0000119844,0.001735759],"genre_scores_gemma":[0.985218,0.0005294199,0.0002858875,0.0001411448,0.00001537323,0.00007493019,0.01302477,0.000005640355,0.0007047705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09749532,"threshold_uncertainty_score":0.1961389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00949092247211723,"score_gpt":0.2543595258447902,"score_spread":0.244868603372673,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}